Despite Nitrous oxide (N2O) being the most widely used anesthetics in dental and other medical applications, it is associated with global warming and stratospheric ozone destruction. With globalization, a larger amount of N2O emissions arearticulated especially from human activities (30%, 6.7 Tg N per year), which are primarily dominated by agriculture that is even above the emissions of all oceans (26%). The synthesis of N2O reflects the general chemistry and readily from a substrate Nitric oxide (NO) in the environment. The modeling of infectious disease dynamics covering common pathogen-transmission factors, for example intrinsic (or microbes nutrient supply) at a population level, is indeed imperative to curb the menace of any disease. Nonetheless, in areas where novel coronavirus disease (COVID-19) was at its worst, for example, Wuhan China, Mumbai India, Milan Italy, Washington USA etc., the reduction in N2O emissions was well noticed. Nonetheless, viruses exhibit greater mobility than humans and hijack nutrients including nitrogen to complete their epidemiological cycle all due to limited sequence space of viral genomes, the high probability of genetic drift, extremely large population sizes, the high mutation and recombination rates. In consequence of drastic fall in N2O emissions, lower human transport can not be an all alone contributor, but contrarily it may also be associated with coronavirus intrinsic factors. This prompted us to analyze freely accessible and large global data from two authenticated sources, the World Health Organization and World Bank. We hereby argue that intrinsic factor N2O emissions fueling the COVID-19 progression significantly. Entire predictions were found consistent with the recently observed shreds of evidence. These insights enhanced scientific ability to interrogate viral epidemiology and recommended a 7-points framework covering all-natural lifestyle and dietary supplements for COVID-19 prevention before the arrival of a front-line therapeutic(s) or preventable vaccine.
Competing Interest Statement
The authors have declared no competing interest.
Graphic Era Hill University
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv